Induction and regulation of matrix metalloproteinase-12in human airway smooth muscle cells

[1]  A. Takeshita,et al.  Interleukin-1 stimulates cytokines, prostaglandin E2 and matrix metalloproteinase-1 production via activation of MAPK/AP-1 and NF-kappaB in human gingival fibroblasts. , 2005, Cytokine.

[2]  J. Tichelaar,et al.  Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. , 2005, American journal of respiratory cell and molecular biology.

[3]  A. Nicholson,et al.  Regulation of TGF-beta 1-induced connective tissue growth factor expression in airway smooth muscle cells. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[4]  J. Gunn,et al.  Human bronchial epithelial cells express and secrete MMP-12. , 2004, Biochemical and biophysical research communications.

[5]  H. Hsieh,et al.  Involvement of p42/p44 MAPK, p38 MAPK, JNK and nuclear factor‐kappa B in interleukin‐1β‐induced matrix metalloproteinase‐9 expression in rat brain astrocytes , 2004, Journal of neurochemistry.

[6]  I. Adcock,et al.  Effects of interleukin-1beta, interleukin-13 and transforming growth factor-beta on gene expression in human airway smooth muscle using gene microarrays. , 2004, European journal of pharmacology.

[7]  S. Watson,et al.  Matrix metalloproteinase expression and activity in human airway smooth muscle cells , 2004, British journal of pharmacology.

[8]  S. Chakraborti,et al.  Regulation of matrix metalloproteinases: An overview , 2003, Molecular and Cellular Biochemistry.

[9]  M. C. Ovejero,et al.  Matrix metalloproteinase-12 (MMP-12) in osteoclasts: new lesson on the involvement of MMPs in bone resorption. , 2004, Bone.

[10]  A. Nicholson,et al.  Regulation of TGF-β1-induced connective tissue growth factor expression in airway smooth muscle cells , 2004 .

[11]  S. Hirst.  Regulation of airway smooth muscle cell immunomodulatory function: role in asthma , 2003, Respiratory Physiology & Neurobiology.

[12]  J. Burgess,et al.  Airway smooth muscle—its relationship to the extracellular matrix , 2003, Respiratory Physiology & Neurobiology.

[13]  M. John,et al.  Role of c‐jun N‐terminal kinase in the induced release of GM‐CSF, RANTES and IL‐8 from human airway smooth muscle cells , 2003, British journal of pharmacology.

[14]  Y. Sasaguri,et al.  Matrix metalloproteinase‐12 gene expression in human vascular smooth muscle cells , 2003, Genes to cells : devoted to molecular & cellular mechanisms.

[15]  Gillian Murphy,et al.  Metalloproteinase inhibitors: biological actions and therapeutic opportunities , 2002, Journal of Cell Science.

[16]  B. Ma,et al.  Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling. , 2002, The Journal of clinical investigation.

[17]  Judith Sylvester,et al.  Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes. , 2002, Matrix biology : journal of the International Society for Matrix Biology.

[18]  E. Kerkelä,et al.  Human macrophage metalloelastase (MMP-12) expression is induced in chondrocytes during fetal development and malignant transformation. , 2001, Bone.

[19]  K. Chung,et al.  Cytokines in chronic obstructive pulmonary disease , 2001, European Respiratory Journal.

[20]  B. Ma,et al.  Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. , 2000, The Journal of clinical investigation.

[21]  Hong Wang,et al.  Transforming Growth Factor-β1 Inhibits Cytokine-mediated Induction of Human Metalloelastase in Macrophages* , 2000, The Journal of Biological Chemistry.

[22]  T. Watanabe,et al.  Induction and regulation of matrix metalloproteinase-12 by cytokines and CD40 signaling in monocyte/macrophages. , 2000, Biochemical and biophysical research communications.

[23]  J. Woessner,et al.  Matrix metalloproteinases and TIMPs , 2000 .

[24]  A. Knox,et al.  Autocrine production of matrix metalloproteinase-2 is required for human airway smooth muscle proliferation. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[25]  A. Manning,et al.  Jun N-terminal kinase in rheumatoid arthritis. , 1999, The Journal of pharmacology and experimental therapeutics.

[26]  R. Panettieri,et al.  Regulation of gelatinases in human airway smooth muscle cells: mechanism of progelatinase A activation. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[27]  Simon C Watkins,et al.  Syntaxin 1A inhibits regulated CFTR trafficking in Xenopus oocytes. , 1999, American journal of physiology. Cell physiology.

[28]  T Kobayashi,et al.  Expression and localization of matrix metalloproteinase-12 in the aorta of cholesterol-fed rabbits: relationship to lesion development. , 1998, The American journal of pathology.

[29]  S. Shapiro,et al.  Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. , 1997, Science.

[30]  K. Colston,et al.  Vitamin D derivatives inhibit the mitogenic effects of IGF-I on MCF-7 human breast cancer cells. , 1997, The Journal of endocrinology.

[31]  P. Howarth,et al.  Transforming growth factor-beta 1 in asthma. Measurement in bronchoalveolar lavage fluid. , 1997, American journal of respiratory and critical care medicine.

[32]  H. V. Van Wart,et al.  Hydrolysis of a Broad Spectrum of Extracellular Matrix Proteins by Human Macrophage Elastase* , 1997, The Journal of Biological Chemistry.

[33]  P. Cohen,et al.  Leukotriene D4 induces MMP-1, which functions as an IGFBP protease in human airway smooth muscle cells. , 1996, The American journal of physiology.

[34]  S. Chandler,et al.  Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein. , 1996, Biochemical and biophysical research communications.

[35]  A. Sousa,et al.  Expression of interleukin-1 beta (IL-1beta) and interleukin-1 receptor antagonist (IL-1ra) on asthmatic bronchial epithelium. , 1996, American journal of respiratory and critical care medicine.

[36]  K Y Hui,et al.  A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). , 1994, The Journal of biological chemistry.

[37]  Y. Nonomura,et al.  Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. , 1993, The Journal of biological chemistry.

[38]  T. Ley,et al.  Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. , 1993, The Journal of biological chemistry.

[39]  H. Birkedal‐Hansen,et al.  Matrix metalloproteinases: a review. , 1993, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[40]  S. Mattoli,et al.  Cytokine mRNA profile and cell activation in bronchoalveolar lavage fluid from nonatopic patients with symptomatic asthma. , 1992, Chest.

[41]  D. Broide,et al.  Cytokines in symptomatic asthma airways. , 1992, The Journal of allergy and clinical immunology.

[42]  J. Woessner,et al.  Matrix metalloproteinases and their inhibitors in connective tissue remodeling , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.